Institution
Shanghai Jiao Tong University
Education•Shanghai, Shanghai, China•
About: Shanghai Jiao Tong University is a education organization based out in Shanghai, Shanghai, China. It is known for research contribution in the topics: Population & Cancer. The organization has 157524 authors who have published 184620 publications receiving 3451038 citations. The organization is also known as: Shanghai Communications University & Shanghai Jiaotong University.
Topics: Population, Cancer, Microstructure, Cell growth, Metastasis
Papers published on a yearly basis
Papers
More filters
••
TL;DR: To investigate the risk of adverse pregnancy outcomes among adolescents in 29 countries, a large number of countries and territories are considered to be at risk.
642 citations
••
Leipzig University1, Shanghai Jiao Tong University2, Iuliu Hațieganu University of Medicine and Pharmacy3, Yonsei University4, University of Paris5, University of Pavia6, University of Malaya7, The Chinese University of Hong Kong8, University of Calgary9, Hiroshima University10, Goethe University Frankfurt11, Paris Diderot University12
TL;DR: CAP provides a standardized non-invasive measure of hepatic steatosis and factors such as the underlying disease, BMI and diabetes must be taken into account when interpreting CAP.
641 citations
••
TL;DR: The in situ ATRP (atom transfer radical polymerization) "grafting from" approach was successfully applied to graft poly(methyl methacrylate) (PMMA) onto the convex surfaces of multiwalled carbon nanotubes (MWNT).
Abstract: The in situ ATRP (atom transfer radical polymerization) “grafting from” approach was successfully applied to graft poly(methyl methacrylate) (PMMA) onto the convex surfaces of multiwalled carbon nanotubes (MWNT). The thickness of the coated polymer layers can be conveniently controlled by the feed ratio of MMA to preliminarily functionalized MWNT (MWNT-Br). The resulting MWNT-based polymer brushes were characterized and confirmed with FTIR, 1H NMR, SEM, TEM, and TGA. Moreover, the approach has been extended to the copolymerization system, affording novel hybrid core−shell nanoobjects with MWNT as the core and amphiphilic poly(methyl methacrylate)-block-poly(hydroxyethyl methacrylate) (PMMA-b-PHEMA) as the shell. The approach presented here may open an avenue for exploring and preparing novel carbon nanotubes-based nanomaterials and molecular devices with tailor-made structure, architecture, and properties.
641 citations
••
Nicholas J Kassebaum1, Ryan M Barber1, Zulfiqar A Bhutta2, Zulfiqar A Bhutta3 +613 more•Institutions (272)
TL;DR: In this article, the authors quantified maternal mortality throughout the world by underlying cause and age from 1990 to 2015 for ages 10-54 years by systematically compiling and processing all available data sources from 186 of 195 countries and territories.
641 citations
••
TL;DR: Early intensive lowering of elevated blood pressure (BP) after acute intracerebral haemorrhage (ICH) was evaluated in this article, as a run-in phase to a larger trial.
Abstract: Summary Background There is much uncertainty about the effects of early lowering of elevated blood pressure (BP) after acute intracerebral haemorrhage (ICH). Our aim was to assess the safety and efficiency of this treatment, as a run-in phase to a larger trial. Methods Patients who had acute spontaneous ICH diagnosed by CT within 6 h of onset, elevated systolic BP (150–220 mm Hg), and no definite indication or contraindication to treatment were randomly assigned to early intensive lowering of BP (target systolic BP 140 mm Hg; n=203) or standard guideline-based management of BP (target systolic BP 180 mm Hg; n=201). The primary efficacy endpoint was proportional change in haematoma volume at 24 h; secondary efficacy outcomes included other measurements of haematoma volume. Safety and clinical outcomes were assessed for up to 90 days. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00226096. Findings Baseline characteristics of patients were similar between groups, but mean haematoma volumes were smaller in the guideline group (12·7 mL, SD 11·6) than in the intensive group (14·2 mL, SD 14·5). From randomisation to 1 h, mean systolic BP was 153 mm Hg in the intensive group and 167 mm Hg in the guideline group (difference 13·3 mm Hg, 95% CI 8·9–17·6 mm Hg; p Interpretation Early intensive BP-lowering treatment is clinically feasible, well tolerated, and seems to reduce haematoma growth in ICH. A large randomised trial is needed to define the effects on clinical outcomes across a broad range of patients with ICH. Funding National Health and Medical Research Council of Australia.
640 citations
Authors
Showing all 158621 results
Name | H-index | Papers | Citations |
---|---|---|---|
Meir J. Stampfer | 277 | 1414 | 283776 |
Richard A. Flavell | 231 | 1328 | 205119 |
Jie Zhang | 178 | 4857 | 221720 |
Yang Yang | 171 | 2644 | 153049 |
Lei Jiang | 170 | 2244 | 135205 |
Gang Chen | 167 | 3372 | 149819 |
Thomas S. Huang | 146 | 1299 | 101564 |
Barbara J. Sahakian | 145 | 612 | 69190 |
Jean-Laurent Casanova | 144 | 842 | 76173 |
Kuo-Chen Chou | 143 | 487 | 57711 |
Weihong Tan | 140 | 892 | 67151 |
Xin Wu | 139 | 1865 | 109083 |
David Y. Graham | 138 | 1047 | 80886 |
Bin Liu | 138 | 2181 | 87085 |
Jun Chen | 136 | 1856 | 77368 |